![Murray Stewart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Murray Stewart
Direktor/Vorstandsmitglied bei X4 PHARMACEUTICALS, INC.
Vermögen: 193 419 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paula Ragan | M | 54 | 10 Jahre | |
Paul Carter | M | 63 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 14 Jahre |
Mark Dipaolo | M | 53 | 3 Jahre | |
Sandipkumar S. Kapadia | M | 54 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 4 Jahre |
Stephen P. Squinto | M | 67 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 4 Jahre |
Chahra Khaoua Epouse Louafi | F | 53 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 4 Jahre |
Odysseas Kostas | M | 49 | 1 Jahre | |
Johannes G. C. P. Schikan | M | 66 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 5 Jahre |
Phil Thomson | M | - | 13 Jahre | |
Luca Santarelli | M | 55 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 5 Jahre |
Emma Walmsley | F | 55 | 14 Jahre | |
Thomas Woiwode | M | 52 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 5 Jahre |
Adam Mostafa | M | 44 | 6 Jahre | |
Mary DiBiase | M | 63 | 7 Jahre | |
David Connolly | M | - | 5 Jahre | |
Jesse Goodman | M | 72 | 8 Jahre | |
Keith Horn | M | 66 | 1 Jahre | |
Patrice Bonfiglio | F | 40 | 1 Jahre | |
Tony Wood | M | - | 7 Jahre | |
Diane Sullivan | F | 62 | 1 Jahre | |
Françoise de Craecker | F | 62 | 3 Jahre | |
Michael Wyzga | M | 69 | 6 Jahre | |
Stuart Arbuckle | M | 58 | 5 Jahre | |
Paul Cohen | M | 49 | 1 Jahre | |
Jennifer Good | F | 59 | 5 Jahre | |
David McGirr | M | 69 | 7 Jahre | |
Camille Bedrosian | M | 71 | 4 Jahre | |
Lynn Tetrault | F | 61 | 4 Jahre | |
Louis Sterling | M | 45 | 1 Jahre | |
Bill Aliski | M | 75 | 5 Jahre | |
Alison Lawton | F | 62 | 4 Jahre | |
Gary Bridger | M | 61 | 6 Jahre | |
Timothy Woodthorpe | M | - | 24 Jahre | |
Pamela Cramer | F | 50 | 3 Jahre | |
Jim Flaherty | M | - | 5 Jahre | |
Frannie DeFranco | F | - | 14 Jahre | |
Anita Kidgell | F | - | 16 Jahre | |
Sally Jackson | F | - | 23 Jahre | |
Elisabeth Crönert-Bendell | M | - | 3 Jahre | |
Joseph Shulman | M | 49 | 4 Jahre | |
Mark Baldry | M | 60 | 2 Jahre | |
Diana Conrad | F | - | 8 Jahre | |
Yann Mazabraud | M | 51 | 4 Jahre | |
R. Woods | M | 56 | 1 Jahre | |
Christophe Arbet-Engels | M | - | 1 Jahre | |
María Cristina de Luna Basagoiti | F | - | 14 Jahre | |
Luke Miels | M | - | 7 Jahre | |
Art Taveras | M | 60 | 4 Jahre | |
Victoria Whyte | F | - | 15 Jahre | |
Christian Meyer | M | 56 |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | - |
Jennifer Chien | F | 49 | 4 Jahre | |
Barbara Beirer | M | - |
Vivli Center For Global Clinical Research Data
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Keith Gottesdiener | M | 70 | 9 Jahre | |
René Russo | M | 49 | 6 Jahre | |
Gregory Perry | M | 63 | 1 Jahre | |
Andrew Witty | M | 59 | - | |
Moncef Slaoui | M | 64 | 11 Jahre | |
Philip Hampton | M | 70 | 4 Jahre | |
Michael Dennis Price | M | 66 | 3 Jahre | |
Thomas Mount | M | - | 7 Jahre | |
Saul Charles Klein | M | 53 | 2 Jahre | |
Kevin Kotler | M | 53 | 2 Jahre | |
Roy Anderson | M | 76 | 11 Jahre | |
William Louv | M | - | 21 Jahre | |
Patrick J. T. Vallance | M | 64 | - | |
Sarah Elton-Farr | F | - | 4 Jahre | |
Peter Traber | M | 69 | 3 Jahre | |
Anjali Bansal | F | 53 | 6 Jahre | |
Alfonso Zulueta | M | 61 | 1 Jahre | |
Balbir Kelly Bisla | F | - | 4 Jahre | |
Derek Meisner | M | 53 | 3 Jahre | |
Wouter Joustra | M | 35 | 1 Jahre | |
Ravi Rao | M | 55 | 7 Jahre | |
Patrick Malloy | M | - | - | |
Robert Carr | M | - | 26 Jahre | |
Adam Berger | M | - | 1 Jahre | |
Scott Applebaum | M | 57 | - | |
Vindi Banga | M | 69 | 7 Jahre | |
Urs Rohner | M | 65 | 9 Jahre | |
Richard Sykes | M | 79 | 7 Jahre | |
Judy Lewent | F | 75 | 10 Jahre | |
H. Culp | M | 60 | 9 Jahre | |
Laurie Glimcher | M | 72 | 5 Jahre | |
Jan van Heek | M | 75 | 13 Jahre | |
Deryck Charles Maughan | M | 76 | 12 Jahre | |
Ian Maurice Gray Prosser | M | 81 | 9 Jahre | |
Robert Wilson | M | 81 | 11 Jahre | |
Christopher Gent | M | 75 | 11 Jahre | |
John David Coombe | M | 79 | 5 Jahre | |
Dame Cox | F | 64 | 6 Jahre | |
Michèle Barzach | M | - | 7 Jahre | |
Crispin Davis | M | 75 | 10 Jahre | |
Per Wold-Olsen | M | 76 | 1 Jahre | |
Stacey Cartwright | F | 60 | 5 Jahre | |
Gerardus Johannes Wijers | M | 74 | 3 Jahre | |
Todd Foley | M | 52 | 7 Jahre | |
Simon Dingemans | M | 61 | 8 Jahre | |
Julian Heslop | M | 70 | 13 Jahre | |
Christopher Viehbacher | M | 64 | 20 Jahre | |
Geraldine Murphy | F | - | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 46 | 46,00% |
Vereinigte Staaten | 29 | 29,00% |
Irland | 12 | 12,00% |
Schweiz | 11 | 11,00% |
Kanada | 4 | 4,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Murray Stewart
- Persönliches Netzwerk